Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism

Author:

Eguren-Santamaría Iñaki123,Rodríguez Inmaculada13,Herrero-Martin Claudia13,Fernández de Piérola Eva13,Azpilikueta Arantza13,Sánchez-Gregorio Sandra13,Bolaños Elixabet13,Gomis Gabriel13,Molero-Glez Paula13,Chacón Enrique4,Mínguez José Ángel4,Chiva Santiago5,Diez-Caballero Fernando5,de Andrea Carlos36,Teijeira Álvaro137,Sanmamed Miguel F.1237,Melero Ignacio3789ORCID

Affiliation:

1. Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain

2. Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain

3. Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain

4. Gynecology & Obstetrics Department, Clínica Universidad de Navarra, Pamplona, Spain

5. Urology Department, Clínica Universidad de Navarra, Pamplona, Spain

6. Pathology Department, Clínica Universidad de Navarra, Pamplona, Spain

7. Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain

8. Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain

9. Nuffield Department of Medicine, University of Oxford, Oxford, UK

Funder

Fundación Científica AECC Clinico Junior

Publisher

Informa UK Limited

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3